OPEN LABEL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF YOKUKANSAN, A TRADITIONAL ASIAN MEDICINE, IN DEMENTIA WITH LEWY BODIES
Open Access
- 13 May 2011
- journal article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 59 (5) , 936-938
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortexProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2008
- Suppressive effect of Yokukansan on excessive release of glutamate and aspartate in the hippocampus of zinc-deficient ratsNutritional Neuroscience, 2008
- A Randomized, Observer-Blind, Controlled Trial of the Traditional Chinese Medicine Yi-Gan San for Improvement of Behavioral and Psychological Symptoms and Activities of Daily Living in Dementia PatientsThe Journal of Clinical Psychiatry, 2005
- Effect of risperidone on behavioral and psychological symptoms and cognitive function in dementia.The Journal of Clinical Psychiatry, 2001
- Reliability and validity of the Japanese version of the Zarit Caregiver Burden InterviewPsychiatry and Clinical Neurosciences, 1997
- “Mini-mental state”Journal of Psychiatric Research, 1975